Leuven site / en Belgium – a home for innovation /about-ucb/magazine/detail/article/belgium-a-home-for-innovation <span>Belgium – a home for innovation</span> <div class="field field--name-field-newsroom-author-title field--type-string field--label-above field__items"> Dhaval Patel, Patient Value Early Solutions </div> <span><span lang about="/user/8781" typeof="schema:Person" property="schema:name" datatype content="Vlastimil.Vanco@ucb.com">Vanco Vlastimi…</span></span> <span><time datetime="2022-09-30T14:36:32+02:00" title="Friday 30 September 2022 - 14:36">Fri 30/09/2022 - 14:36</time> </span> <div class="field field--name-field-newsroom-author-image field--type-entity-reference field--label-above field__items"> <article class="media media--type-image media--view-mode-default"> <div class="field field--name-image field--type-image field--label-hidden field__items"> <img loading="lazy" src="/sites/default/files/styles/ucb_header_image/public/2022-09/Dhaval-Patel-portrait%20-%20Copy.png.webp?itok=DxWw7lfd" width="100" height="100" typeof="foaf:Image"> </div> </article> </div> <div class="field field--name-field-newsroom-content field--type-text-long field--label-above field__items"> <p><br> September has seen a lot of time spent discussing and shaping innovation in the EU. This week (September 28-29<sup>th</sup>) the European Commission held its European Research and Innovation Days – their flagship event on research and innovation. This event, dedicated to promoting research and innovation across the EU, provided a space for policymakers, researchers, entrepreneurs, and the public to come together and debate and shape the future of research and innovation in Europe.&nbsp;<br> <br> In addition, earlier this month the Commission published its 2022 European Innovation Scoreboard (EIS). The annual EIS provides a comparative assessment of the research and innovation performance of EU Member States and the relative strengths and weaknesses of their research and innovation systems. Based on their scores, Members States fall into four performance groups:&nbsp;</p> <ol> <li>Innovation leaders (performance is above 125% of the EU average)&nbsp;</li> <li>Strong innovators (between 100% and 125% of the EU average)&nbsp;</li> <li>Moderate innovators (between 70% and 100% of the EU average)&nbsp;</li> <li>Emerging innovators (below 70% of the EU average). Sweden continues to be the best performer in the EU.&nbsp;</li> </ol> <p><br> Belgium was scored as an ‘innovation leader’, based on multiple factors over four main types of domains that include; framework conditions (human resources, attractiveness of research systems, digitalisation), investments, innovation activities and impact (sustainability, exports, employment). This is something I am pleased to see; it confirms that year after year Belgium remains a good place to innovate and ratifies ½ðºÌÓéÀֳǒs continued investment in our high-tech Braine Campus (one of three key strategic research centres for ½ðºÌÓéÀÖ³Ç), in the establishment of our Leuven satellite, as well as an R&amp;D presence in our global headquarters in Anderlecht.&nbsp;<br> <br> From ground-breaking scientific innovation to high-tech manufacturing, our Belgian ½ðºÌÓéÀÖ³Ç sites are home to a thriving and dynamic community of scientists, technicians, engineers, and manufacturing personnel who will enable us to be faster, flexible, smarter and more scalable - making our company in Belgium one of the most exciting places for creative minds and people determined to innovate, pushing the beyond the boundaries of what’s possible and shaping the future. After all we are an R&amp;D company and R&amp;D is all about the future.&nbsp;<br> <br> At ½ðºÌÓéÀÖ³Ç, innovation goes into the medicines we discover, develop, and deliver. To achieve this, we work hard at providing the right surroundings and facilities, creating a culture that nurtures and fosters innovation, hiring great people and looking beyond our own boundaries to acquire new knowledge and skills. If you want to join a company that takes innovation seriously then you have arrived at the place - we have unique opportunities and exciting positions waiting for you!<br> <br> <a href="https://careers.ucb.com/global/en/ucb-gene-therapy-">Take a look</a><br> &nbsp;</p> </div> <div class="field field--name-field-newsroom-category field--type-entity-reference field--label-above field__items"> <a href="/taxonomy/term/1907" hreflang="en">about ucb</a> </div> <div class="field field--name-field-newsroom-tags field--type-entity-reference field--label-above field__items"> <a href="/taxonomy/term/1279" hreflang="en">Innovation</a> <a href="/taxonomy/term/5438" hreflang="en"> R&amp;D</a> <a href="/taxonomy/term/10221" hreflang="en">European Research and Innovation Days</a> <a href="/taxonomy/term/10231" hreflang="en">Braine Campus</a> <a href="/taxonomy/term/10241" hreflang="en">Leuven site</a> </div> <div> <div class="comments-wrapper"> <div class="comment-area"> <h2 class="red">Leave a Comment</h2> <drupal-render-placeholder callback="comment.lazy_builders:renderForm" arguments="0=node&amp;1=14601&amp;2=field_newsroom_askexpert&amp;3=ask_expert" token="trqrJkCr1-cMzTxJNud731rYqK-28e18p2PVNj8a_zw"></drupal-render-placeholder> <span class="toggle-form js-toggle-form"></span> </div> </div> </div> <span class="a2a_kit a2a_kit_size_16 addtoany_list" data-a2a-url="/about-ucb/magazine/detail/article/belgium-a-home-for-innovation" data-a2a-title="Belgium – a home for innovation"><a class="a2a_dd addtoany_share" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.ucb.com%2Fabout-ucb%2Fmagazine%2Fdetail%2Farticle%2Fbelgium-a-home-for-innovation&amp;title=Belgium%20%E2%80%93%20a%20home%20for%20innovation"></a><a class="a2a_button a2a_button_facebook"><img src="/themes/custom/ucb_premier/images/a2a/facebook-icon.svg" width="16" height="16" border="0" alt="linkedin"></a><a class="a2a_button a2a_button_linkedin"><img src="/themes/custom/ucb_premier/images/a2a/linkedin-icon.svg" width="16" height="16" border="0" alt="linkedin"></a><a class="a2a_button a2a_button_twitter"><img src="/themes/custom/ucb_premier/images/a2a/twitter-icon.svg" width="16" height="16" border="0" alt="twitter"></a></span> <div class="field field--name-field-like field--type-likes-dislikes field--label-above field__items"> <div class="like_dislike"> <div class="like"> <a rel="nofollow" class="use-ajax" href="/like-dislike/like/eyJlbnRpdHlfdHlwZSI6Im5vZGUiLCJlbnRpdHlfaWQiOiIxNDYwMSIsImZpZWxkX25hbWUiOiJmaWVsZF9saWtlIiwibGlrZXMiOiI0NjEiLCJkaXNsaWtlcyI6Ii03MiJ9"></a> <span class="like-14601"> 461 Likes </span> </div> </div> <div id="like_dislike_status"></div> </div> Fri, 30 Sep 2022 12:36:32 +0000 Vanco Vlastimil (½ðºÌÓéÀÖ³Ç S.A.) 14601 at